Compounds > ecteinascidin 743
Page last updated: 2024-09-02

ecteinascidin 743 and Liver Diseases

ecteinascidin 743 has been researched along with Liver Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davies, R; Dinsdale, D; Donald, S; Edwards, R; Gant, TW; Gescher, AJ; Greaves, P; Judah, DJ; Lopez Lazaro, L; Riley, J; Smith, AG; Verschoyle, RD1
Colombo, T; D'Incalci, M; Donald, S; Frapolli, R; Gant, TW; Gescher, AJ; Greaves, P; Jimeno, J; Lopez-Lazaro, L; Meco, D; Riccardi, R; Verschoyle, RD; Zaffaroni, M; Zucchetti, M1
Bertulli, R; Casali, PG; D'Incalci, M; Dileo, P; Gescher, A; Grosso, F; Jimeno, J; Piovesan, C; Sanfilippo, R; Stacchiotti, S1

Other Studies

3 other study(ies) available for ecteinascidin 743 and Liver Diseases

ArticleYear
Hepatobiliary damage and changes in hepatic gene expression caused by the antitumor drug ecteinascidin-743 (ET-743) in the female rat.
    Cancer research, 2002, Aug-01, Volume: 62, Issue:15

    Topics: Animals; Antineoplastic Agents, Alkylating; Bile Duct Diseases; Bilirubin; Cell Division; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Dioxoles; Female; Gene Expression; Isoquinolines; Liver; Liver Diseases; Rats; Rats, Wistar; Tetrahydroisoquinolines; Trabectedin

2002
Complete protection by high-dose dexamethasone against the hepatotoxicity of the novel antitumor drug yondelis (ET-743) in the rat.
    Cancer research, 2003, Sep-15, Volume: 63, Issue:18

    Topics: Animals; Antineoplastic Agents, Phytogenic; Aryl Hydrocarbon Hydroxylases; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP3A; Dexamethasone; Dioxoles; Down-Regulation; Drug Interactions; Female; Gene Expression; Isoquinolines; Liver; Liver Diseases; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Oligonucleotide Array Sequence Analysis; Oxidoreductases, N-Demethylating; Rats; Rats, Inbred F344; Rats, Wistar; Tetrahydroisoquinolines; Trabectedin

2003
Steroid premedication markedly reduces liver and bone marrow toxicity of trabectedin in advanced sarcoma.
    European journal of cancer (Oxford, England : 1990), 2006, Volume: 42, Issue:10

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Dioxoles; Disease-Free Survival; Female; Humans; Liver Diseases; Male; Middle Aged; Premedication; Sarcoma; Steroids; Tetrahydroisoquinolines; Trabectedin

2006